- Home
- NKTR vs PDO Comparison
NKTR vs PDO Comparison
Compare NKTR & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKTR | PDO |
|---|---|---|
| Founded | 1990 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NKTR | PDO |
|---|---|---|
| Price | $59.74 | $12.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $146.67 | N/A |
| AVG Volume (30 Days) | ★ 857.2K | 601.2K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $8.27 | $12.37 |
| 52 Week High | $109.00 | $14.25 |
Technical Indicators
Market Signals| Indicator | NKTR | PDO |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 49.14 |
| Support Level | $53.27 | $12.66 |
| Resistance Level | $61.98 | $14.13 |
| Average True Range (ATR) | 2.83 | 0.15 |
| MACD | 0.79 | 0.01 |
| Stochastic Oscillator | 51.98 | 55.32 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.